CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species

Journal of Immunology

Volumn 160, Issue 10, 1998, Pages 4755-4761

  Yi, Ae Kyung ^a   Tuetken, Rebecca ^a   Redford, Thomas ^b   Waldschmidt, Marianella ^a   Kirsch, Jeffrey ^a   Krieg, Arthur M ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN; CD40 ANTIGEN; CHLOROQUINE; LIPOPOLYSACCHARIDE; MONENSIN; OXYGEN RADICAL; PHORBOL 12 ACETATE 13 MYRISTATE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; DNA DETERMINATION; DNA SEQUENCE; IMMUNOSTIMULATION; LEUKOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TRANSCRIPTION REGULATION;

ANIMALS; CHLOROQUINE; CYTOKINES; DINUCLEOSIDE PHOSPHATES; DNA, BACTERIAL; DNA-BINDING PROTEINS; HYDROGEN-ION CONCENTRATION; I-KAPPA B PROTEINS; LEUKOCYTES; MICE; MICE, INBRED DBA; NF-KAPPA B; REACTIVE OXYGEN SPECIES;

EID: 0032525023     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bird, A. P. 1987. CpG islands as gene markers in the vertebrate nucleus. Trends Genet. 3:342.
2. Messina, J. P., G. S. Gilkeson, and D. S. Pisetsky. 1991. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 147:1759.
3. Halpern, M. D., R. J. Kurlander, and D. S. Pisetsky. 1996. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α. Cell. Immunol. 167:72.
4. Yi, A.-K., and A. M. Krieg. 1998. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of IκBa and IκBβ and sustained activation of nuclear factor-κB/c-Rel. J. Immunol. 160:1240.
5. Stacey, K. J., M. J. Sweet, and D. A Hume. 1996. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157:2116.
6. Tokunaga, T., H. Yamamoto, S. Shimada, H . Abe, T. Fukuda, Y. Fujisawa, Y. Furutani, O. Yano, T. Kataoka, T. Sudo, N. Makiguchi, and T. Suganuma. 1984. Amitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and anti-tumor activity. J. Natl. Cancer Inst. 72:955.
7. Yamamoto, S., E. Kuramoto, S. Shimada, and T. Tokunaga. 1988. In vitro augmentation of natural killer cell activity and production of interferon-α/β and -γ with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn. J. Cancer Res. 79:866.
8. Cowdery, J. S., J. H. Chace, A.-K. Yi, and A. M. Krieg. 1996. Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 156:4570.
9. Ballas, Z. K., W. L. Rasmussen, and A. M. Krieg. 1996. Bacterial DNA induces in vivo imerferon-γ production by NK cells and increases sensitivity to endotoxin. J. Immunol. 157:1840.
10. Sparwasser, T., T. Miethke, G. Lipford, K. Borschert, H. Hacker, K. Heet, and H. Wagner. 1997. Bacterial DNA causes septic shock. Nature 386:336.
11. Krieg, A. K., A.-K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546.
12. Klinman, D., A.-K. Yi, S. L. Beaucage, J. Conover, and A. M. Krieg. 1996. CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6. IL-12 and IFN-γ Proc. Natl. Acad. Sci. USA 93:2879.
13. Yi, A.-K., D. M. Klinman, T. L. Martin, S. Matson, and A. M. Krieg. 1996. Rapid immune activation by CpG motifs in bacterial DNA; systemic induction of IL-6 transcription through un anlioxidant-sensilive pathway. J. Immunol. 157:5394.
14. L. J. Immunol. 157:4918.
15. Krieg, A. M. 1996. An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA. J. Lab. Clin. Med. 128:128.
16. Tonkinson, J. L., and C. A. Stein. 1994. Patterns of intracellular compartmentalization trafficking and acidification of 5′-fluorcscein labeled phosphodiester and phosphoroihioate oligodeoxynucleotides in HL60 cells. Nucleic Acids Res. 22:4268.
17. Krieg, A. M. 1995. Uptake and localization of phosphodiester and chimeric oligodeoxynucleotides in normal and leukemic primary cells. In: Delivery Strategies for Antisense Oligonucleotide Therapeutics. S. Akhtar, ed. CRC Press, Boca Raton, p. 177.
18. Zhao, Q., S. Matson, C. J. Herrara, E. Fisher, H. Yu, A. Waggoner, and A. M. Krieg. 1993. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioaie and methylphosphonate oligonucleotides. Antisense Res. Dev. 3:53.
19. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
20. Briskin, M., M. Damore, R. Law, G. Lee, P. W. Kincade, C. H. Sibley, M. Kuehl, and R. Wall. 1990. Lipopolysaccharide-unresponsive mutant pre-B-cell lines blocked in NF-θB activation. Mol. Cell. Biol. 10:422.
21. Jeong, J.-Y., and D.-M. Jue. 1997. Chloroquine inhibits processing of Tumor necrosis factor in lipopolysaccharide-stimulated Raw 264.7 macrophages. J. Immunol. 158:4901.
22. Marshansky, V., and P. Vinay. 1996. Proton gradient formation in early endosomes from proximal tubules. Biochim. Biophys. Acta 1284:171.
23. Pahl, H. L., B. Kraub, K. Schulze-Ostoff, T. Decker, E. B.-M. Traenckner, M. Vogt, C. Myers, T. Parks, P. Warring, A. Muhlbacher, A.-P. Czernilofsky, and P. A. Baeuerle. 1996. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB. J. Exp. Med. 183:1829.
24. Beauerle, P. A., and T. Henke. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
25. Baldwin, A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
26. Anitescu, M., J. H. Chace, R. Tuetken, A.-K. Yi, D. J. Berg, A. M. Krieg, and J. S. Cowdery. 1997. Interleukin-10 functions in vitro and in vivo to inhibit bacterial DNA-induced secretion of interleukin-12. J. Interferon Cytokine Res. 17:781.
27. Sen, C. K., and L. Packer. 1996. Antioxidant and redox regulation of gene transcription. FASEB J. 10:709.
28. Sato, Y., M. Roman, H. Tighe, D. Lee, M. Corr, M.-D. Nguyen, G. J. Silverman, M. Lotz, D. A. Carson, and E. Raz. 1996. Immuno-stimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352.
29. Klinman, D. M., G. Yamshchikov, and Y. Ishigatsubo. 1997. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158:3635.
30. Kline, J. N., T. J. Waldschmidt, T. R. Businga, J. E. Lemish, J. V. Weinstock, P. S. Thorne, and A. M. Krieg. 1998. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160:255.
31. Chu, R. S., O. S.Targoni, A. M. Krieg, P. V. Lehmann, and C. V. Harding. 1997. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Thl) immunity. J. Exp. Med. 186:1623.
32. Roman, M., E. Martin-Orozco, J. S. Goodman, M.-D. Nguyen, Y. Sato, A. Ronaghy, R. S. Kornbluth, D. D. Richman, D. A. Carson, and E. Raz. 1997. Immune stimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3:849.
33. Davis, H. L., R. Weeratna, T. J. Waldschmidt, L. Tygrett, J. Schorr, and A. M. Krieg. 1998. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:870.
34. Moldoveanu, Z., L. Love-Homan, W. Q. Huang, and A. M. Krieg. 1998. CpG DNA, a novel adjuvant for systemic and mucosat immunization with influenza virus. Vaccine. In press.
35. Weiner, G. J., H.-M. Liu, J. E. Wooldridge, C. E. Dahle, and A. M. Krieg. 1997. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunizaition. Proc. Natl. Acad. Sci. USA 94:10833.
36. Wooldridge, J. E., Z. Ballas, A. M. Krieg, and G. J. Weiner. 1997. Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma. Blood 89:2994.
37. Macfarlane, D. E., L. Manzel, and A. M. Krieg. 1997. Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI-231 B-lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signaling step. Immunology 91:586.
38. Gilkeson, G. S., J. P. Grudier, D. G. Karounos, and D. S. Pisetsky. 1989. Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J. Immunol. 142:1482.
39. Gilkeson, G. S., A. M. M. Pippen, and D. S. Pisetsky. 1995. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J. Clin. Invest. 95:1398.
40. Slater, A. F. G., and A. Cerami. 1992. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355:167.
41. Buus, S., and O. Werdelin. 1984. Chloroquine inhibits accessory cell presentation of soluble natural synthetic protein antigens. Acta Pathol. Microbiol. Immunol. Scand. 92:285.
42. Ferrante, A., B. Rowan-Kelly, W. K. Seow, and Y. H. Thong. 1986. Depression of human polymorphonuclear leukocyte function by anti-malarial drugs. Immunology 58:125.
43. Schwartz, D., T. J. Quinn, P. S. Thorne, S. Sayeed, A.-K. Yi, and A. M. Krieg. 1997. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J. Clin. Invest. 100:68.